Azienda Sanitaria Locale Cn1
- Address
- Via Pier Carlo Boggio 12, 12100 Cuneo, Italy
Azienda Sanitaria Locale Cn1 - Oncology and Neurology Research
Azienda Sanitaria Locale Cn1 is a clinical research center engaged in advanced therapeutic studies across multiple medical disciplines. The center demonstrates particular expertise in precision oncology and neurological disorders, conducting trials that incorporate cutting-edge diagnostic technologies and targeted treatment strategies.
- Circulating tumor DNA (ct-DNA) guided precision therapy in resected colon cancer
- Adjuvant and post-adjuvant treatment intensification strategies for stage II and III colon cancer
- Relapsing multiple sclerosis therapeutic interventions and comparative efficacy studies
In oncology, the center is pioneering the use of circulating tumor DNA monitoring to personalize post-operative treatment for colon cancer patients, evaluating intensive chemotherapy regimens including FOLFOXIRI and targeted therapies for HER2-positive colon cancer. Their neurology program focuses on relapsing multiple sclerosis, comparing novel therapeutic agents with established treatments to optimize patient outcomes through rigorous assessment of relapse rates and safety profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Fondazione GONO G.I.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Sanitaria Locale Cn1
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS | F. Hoffmann-La Roche AG | Phase III | Not Recruiting | Dec 2020 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 1 | Unknown | 2023-03-02 | 2023-03-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.